California Court of Appeal June 3, 2020, B284002 (Risperdal and Invega Cases)

Also known as

United States · · · 03-06-2020

Filed 5/8/20; Certified for Partial Publication 6/3/20 (order attached)

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION THREE

RISPERDAL AND INVEGA B284315, B284002,

CASES B284317

(Los Angeles County

Super. Ct. Nos. BC562540,

BC583302, BC604937)

(JCCP No. 4775)

APPEALS from judgments of the Superior Court of Los

Angeles County, William E. Highberger, Judge. Affirmed in part

and reversed in part.

Bernstein Liebhard and Daniel C. Burke for Plaintiff and

Appellant C.S.

Law Office of Martin N. Buchanan, Martin N. Buchanan;

Engstrom, Lipscomb & Lack and Ann Howitt for Plaintiffs and

Appellants J.D. and J.T.

Drinker Biddle & Reath, Rodney M. Hudson, William A.

Hanssen; Faegre Drinker Biddle & Reath and Rodney M. Hudson

for Defendants and Respondents.

——————————

C.S., J.D., and J.T. (collectively plaintiffs) were adolescents

who were prescribed the antipsychotic drug risperidone after it

was approved by the Food and Drug Administration (FDA) to

treat behavioral symptoms in children with autism. They allege

that risperidone caused them to develop gynecomastia, a

condition characterized by the enlargement of male breast tissue.

Plaintiffs sued risperidone’s manufacturers and distributors,

Janssen Pharmaceuticals, Inc.; Janssen Research and

Development, LLC; Johnson & Johnson; and McKesson

Corporation (collectively and interchangeably, Janssen) for

failure to adequately warn of the risk of gynecomastia on the

drug’s label. Janssen moved for summary judgment on federal

preemption grounds against plaintiffs. Janssen also moved for

summary judgment against the individual plaintiff, C.S., on the

ground that he could not raise a triable issue of fact under New

York’s proximate cause standard, which requires the patient to

show that the treating physician would have changed her

prescribing behavior had she had an adequate warning. The trial

court granted both motions. For the reasons set forth below, we

affirm the summary judgment against C.S.

Read the full text

This document is published by courtlistener.com.

Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.